Gynae Flashcards
Symptoms of cervical ectropions
Normally asyx
PCB, vaginal discharge
Treatment of ectropion
Cryotherapy w/out anaesthesia once smear/colposcopy -ve for malignancy
Causes of cervicitis (acute and chronic)
Acute: STD, ulceration and infection often prolapsed
Chronic: inflammation/infection ie of ectropion
Treatment of cervicitis
Inflammatory smear + discharge
Tx with avulsion but still investigate bleeding
Cervical polyps: epi, syx and tx
Common after 40, usually
What is a nabothian follicle?
Squamous epithelium over columnar = blocks glands –> white glands and opaque swelling on ectocervix
Tx if syx
Definition and Classification of CIN
Definition: atypical cells in Sq epi - larger nuclei + dyskaryosis (atypia)
I - mild - lower 1/3 of epithelium
II - moderate - lower 2/3
III - severe - full thickness (malignant like cells without invasion)
Malignancy = invasion of Basement membrane
Epi of CIN
1/3 of III will get cervical cancer within 10 years
Peak 25-29
HPV 16, 18, 31, 33 - (16+18 vaccinated now before first sex)
OCP and smoking
Immunodef ie steroids or HIV
Pathology of CIN
Columnar to Sq in TZ
HPV turns off tumour suppressor genes and hides cells from immune system
NB CIN is premalignant and predicts risk of developing cervical cancer
Screening schedule for CIN
Smear every 3 years from 25-49, 5 years 50-64, >65 if no smear since 50 or previously abnormal
80% acception rate
Smear test procedure
Cusco speculum and brush –> liquid based cytology (only 2.5% failure) + HPV test
Smear test results (mild/CGIN)
Detects atypical cells not histo abnormalities
Mild = HPV test –> high risk HPV = colposcopy, low/no HPV = back to normal schedule of 3/5y
CGIN = cone biopsy
Smear test results (II/III)
Colposcopy w/ tx - TZ excised w/diathermy/LLETZ = dx and tx
Risk of haemorrhage and preterm delivery
Cervical cancer: Epidemiology
Peak 30s/80s esp 25-29
90% SCC, 10% adenocarcinoma (worse prognosis)
All have HPV - same risks as CIN as it’s premalignant
Inadequate screening and FHx are common
What is a cervical ectropion and what is the cause?
Columnar epithelium visible around the os caused by eversion in pregnancy or puberty
Epidemiology of cervical cancer
Peak 30s and 80s (25-49, esp 25-29)
90% SCC 10% adeno from columnar: worse prognosis
Aetiology of cervical cancer
HPV in ALL cervical cancer
HIV/immunodef
smoking
inadequate screening
Clinical features of cervical cancer: Hx and Ex
Occult: asyx but dx on biopsy/LLETZ
Hx: PCB, IMB, PMB, offensive discharge. PAIN is UNCOMMON
Late: uraemia and haematuria, rectal bleeding and pain (ureters, bladder, rectum and nerves)
Ex: ulcer or mass on cervix or may look normal
Staging of cervical cancer
1ai: dx on microscopy: invasion 4cm diameter
2ai: upper 2/3 vagina w/o parametrial involvement 4cm
2b: parametrium
3: lower vagina or pelvic wall or ureteric obstruction
4: bladder or rectum or pelvis
Anatomy of uterus
Myometrium (smooth muscle) and Endometrium (glandular)
Supported by uterosacral and cardinal (like cervix)
Broad = continuous with pelvic side wall and F tubes
Round = little support but holds blood supply
EM responds to oestrogen and progesterone, basal + spiral arterioles
Fibroids Pathology and Epidemiology
25% of women, esp near menopause, decreased in nulliparous + OCP - oestrogen driven, regress postmenopausally
Benign tumour of the myometrium
Variable size, intramural, subserosal, submucosal (polyp)
Fibroid syx
50% asyx - syx due to size
30% get HMB, IMB if submucosal/polypoid
Pain is rare unless torsion, sarcoma or red degeneration
Urinary if pressure on tract
Reduced fertility esp implantation and tube blocking
Progression of fibroids
Slow growing, calcify post menopausally, HRT increases growth
Degenerate if poor blood supply - red = haemorrhage and necrosis, hyaline = fluid filled
Fibroids in pregnancy
Red degeneration, premature, malpresentation, abnormal lie, obstruction, PPH
Don’t remove at section due to bleeding
Investigation of fibroids
USS
MRI/lap may be needed (MRI sees adenomyosis)
Hysterectomy = visualise change - esp fertility
Hb - bleed = decrease, EPO secretion by fibroids = increase
Tx of fibroids
Asyx = none (monitor for malignancy if large)
Medical: tranexamic acid, NSAIDs and progestogens (often not enough if HMB) but try 1st line
GnRH = decreased fibroid size (menopausal state) - 6m only, 2y with add-back HRT
Surgical: Up to 3cm - remove via hysteroscopy if polypoid/submucosal
Pretreat with GnRH
Myomectomy if medical fails and fertility needed (heavy blood loss)
Complications: section in future due to rupture risk, adhesions
Adenomyosis Pathology
EM and stroma in myometrium
Common around 40y, assoc with EMosis and fibroids
Syx subside after menopause
EM blood can pool in MyoM - chocolate cyst
Clinical features and diagnosis of adenomyosis
May be asyx
Painful, regular HMB common
Uterus enlarged and tender
MRI is dx
Treatment of adenomyosis
IUS or COCP +/- NSAIDs to control HMB
Hysterectomy often required
GnRH trial to see if hysterectomy will work
EM polyps Epidemiology, dx and tx
Benign, common 40-50y, increased oestrogen= cause
Esp tamoxifen postmenopausally
Can contain hyperplasia/carcinoma = HMB/IMB
Dx = hysteroscopy/USS
Tx = avulsion/ resection
Haematometra Path and Syx
Blood accumulation in the uterus
Causes: fibroids, post EM resection, carcinoma, cone biopsy
Congenital imperforate hymen, blind horn - primary amenorrhea
Congenital uterine malformations causes and tx
Failure or mullerian duct fusion @9wk
Renal and pregnancy problems
Malpresenation, transverse lie, preterm, miscarriage, retained placenta
Hysteroscopic tx = septa, lap/open = horns, bicorn = not opened
EM carcinoma Epidemiology
Most common genital tract cancer
60y, 15% premenopausal (1%
Aetiology of EM carcinoma
High oestrogen: progesterone ratio ie unopposed oestrogen
Exogenous oest without prog
Obesity
PCOS/ prolonged amenorrhea, nulliparous, late menopause
tamoxifen = oestrogen agonist in postmen uterus
COCP is protective
Premalignant EM epi and clinical
Epi: 1st cystic then atypical glandular
Rare in reproductive age women - tx with progestogens if uterus needed + 6m EM biopsy
Clinical: PMB (10% risk carcinoma), increasing with age, Premen IMB or recent HMB, CGIN smear and Ex normal
EM carcinoma staging
Stage 1 - confined to uterus a - EM only, b - 1/2 Stage 2 - cervix also a - cervical glands, b - cervical stromal invasion Stage 3 - through uterus a - serosa or adnexae, b - vag/parametrium, c - pelvic nodes, d - paraaortic Stage 4 - distant a - bowel/bladder, b - distant
Ix of EM carcinoma
Abnormal vaginal bleed as for pre/postmen bleed
USS/biopsy EM depending on risk
Staging only possible post-hysterectomy
MRI in those @ risk and suspected spread